Astellas at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Astellas takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on business development, covering how partnering is changing in a shifting global landscape and whether Most Favoured Nations is a game-changer for biotech dealmakers. Astellas also sponsors the meeting.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Astellas Tokyo, Japan | ◇Silver Sponsor |
Japanese pharmaceutical company developing medicines in oncology, ophthalmology, urology and immunology. | Panel Mon Nov 9 13:00–14:00 Navigating partnering and business development in a shifting global landscape How funding conditions, treatment trends and geopolitics are shaping partnerships and acquisitions between drug and biotech companies, with real deal examples. Panel Wed Nov 11 10:00–10:45 Most Favoured Nations: A Game-Changer for Biotech Dealmaker? How the US 'most favoured nation' policy, which ties US drug prices to prices paid abroad, is changing drug deals and European launch plans. |
Instantly find 20 buyers from Astellas
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction